Find consortia

Results Download Results in Excel (.XLS)

Consortium title & disease focus	Tool Development Tools	Biomarker Research Biomarker	Basic Research Basic	Data-Sharing Enabler Data	Product Development Products
1000 Genomes Project Tuberculosis
A GABRIEL Consortium Large-Scale Genome-Wide Association Study of Asthma Asthma
Accelerating Medicines Partnership - Alzheimer's Alzheimer's Disease
Accelerating Medicines Partnership—Autoimmune Diseases (Rheumatoid Arthritis & Lupus) Arthritis, Lupus
Accelerating Medicines Partnership—Diabetes Type 2 Diabetes
Addario Lung Cancer Consortium Lung Cancer
AddNeuroMed Alzheimer's Disease
ADDPLAN DF Consortium
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) Ftld Syndromes
Adverse Drug Response Safety Biomarkers (ADRSB)
All of Us Research Program
Alzheimer’s Disease Genetics Consortium (ADGC) Alzheimer's Disease
Alzheimer’s Disease Neuroimaging Initiative (ADNI) Alzheimer's Disease
Anti-Biopharmaceutical Immunization: prediction and analysis of clinical relevance to minimize the RISK (ABIRISK) Hemophilia A, Inflammatory Diseases, Multiple Sclerosis
Antibody Derivatives As Molecular Agents for Neoplastic Targeting Consortium (ADAMANT) Cancers
Asian Cancer Research Group (ACRG) Oncology
Autonomic Disorders Consortium (ADC) Autoimmune Autonomic Ganglionopathy, Baroreflex Failure, Dopamine Beta-Hydrolyase Deficiency...
Be The Cure (BTCure) Arthritis
Beta Cell Biology Consortium (BCBC) Type 1 Diabetes
Biomarker for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Cardiovascular
Biomarkers Across Neurodegenerative Diseases (BAND) Alzheimer's Disease, Parkinson's Disease
bioMARkers and molecular tumor classification for non-genotoxic CARcinogeneis (MARCAR)
Biomarkers for Enhanced Vaccine ImmunoSafety (BioVacSafe)
Biomarkers of Anti-TNF Treatment Efficacy in Rheumatoid Arthritis–Unresponsive Populations (BATTER-UP) Rheumatoid Arthritis
BIOSAPIENS Network of Excellence
Bloodomics Cardiovascular
Brain Vascular Malformation Consortium (BVMC) Hereditary Hemorrhagic Telangiectasia, Sturge-Weber Syndrome, Cerebral cavernous Malformations
Breast Cancer Somatic Genetics Study (BASIS) Oncology
Brittle Bone Disorders (BBD) Consortium Osteogenesis Imperfecta
Canadian Consortium on Neurodegeneration in Aging (CCNA) Alzheimer's Disease
Canadian Pediatric Cancer Genome Consortium (CPCGC) Oncology
Cancer Genomics Consortium (CGC) Oncology
Cancer Genomics of the Kidney (CAGEKID) Oncology
Cancer Stem Cell Consortium (CSCC) Oncology
Cancer treatment and monitoring through identification of circulating tumor cells and tumor related nucleic acids in blood (CANCER-ID) Cancer
Cardiac Safety Research Consortium (CSRC) Cardiac Safety
CArdioVAscular Research Information System (CAVARIS) Cardiovascular
CFTR 3D-Structure Consortium cystic fibrosis
Childrens Brain Tumor Tissue Consortium (CBTTC) Child Brain Cancer
Chronic Graft Versus Host Disease (cGVHD) Consortium Immune Related Disorders After Allogenic Hematopoietic Cell Tran
Circulating Cells Atherosclerosis
CKD Biomarkers Consortium (BioCon) Chronic Kidney Disease
Clinical Research in ALS and Related Disorders for Therapeutic Development Consortium (CReATe) Frontotemporal Dementia, Hereditary Spastic Paraplegia, Primary Lateral Sclerosis...
Coalition Against Major Diseases (CAMD) Alzheimer's Disease, Parkinson's Disease
Collaborative Chronic Care Network (C3N) Inflammatory Bowel Diseases (Crohn's Disease And Ulcerative Coli
Colon Therapy Research Consortium (COLTHERES) Oncology
CommonMind Consortium Bipolar Disorder, Schizophrenia
Consortium for Metabonomic Toxicology (COMET)
Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Eosinophilic Colitis, Eosinophilic Gastritis, Esophagitis
COPD Biomarker Qualification Consortium (CBQC) Copd
COPDMAP Copd
Critical Path for Parkinson's Parkinson's Disease
Critical Path Institute (C-Path)
Decrease Colorectal Cancer Death (DeCoDe) Oncology
Developing imaging technologies for therapeutic interventions in rare diseases (BIOIMAGE-NMD) Muscular Dystrophy
Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes (BetaBat) Diabetes
Development of Tools (and Prediction Rules) to Time and Select Therapy in Treatment of Preclinical, Early and Established Rheumatoid Arthritis: Creating Enhanced Remedy (TRACER) Arthritis
Diabetes Genetics Replication and Meta-Analysis (DIAGRAM) Consortium Type 2 Diabetes
Diabetes Research on Patient Stratification (DIRECT) Type 2 Diabetes
Duchenne Regulatory Sciences Consortium (D-RSC) Duchenne muscular dystrophy
Dystonia Coalition Blepherospasm, Cervical Dystonia, Craniofacial Dystonia...
eagle-i Consortium
EU-ToxRisk
EUCILIA
EUCLOCK
EURenOmics Rare kidney disease
European Asthma Research and Innovation Partnership (EARIP) Asthma
European large-scale functional genomics in the rat for translational research (EURATRANS)
European Lead Factory (EU Lead Factory)
European Microbicides Project (EMPRO) HIV/AIDS
European Network for Genetic and Genomic Epidemiology (ENGAGE)
European Network for Translational Research in Atrial Fibrillation (EUTRAF) Atrial Fibrillation
European Project on Mendelian Forms of Parkinson’s Disease (MEFOPA) Parkinson's Disease
Evaluation of the Role of Inflammation in Chronic Airways Disease (ERICA) Copd
GeneQol
Genetic Association Information Network (GAIN)
Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer (RESPONSIFY) Oncology
GetReal
Gliogene Consortium Oncology
Global Alliance of Leading Drug Discovery and Development Centers
Global Consortium for Biomarker Standardization Alzheimer's Disease
Global Health Innovative Technology Fund (GHIT) Acute/Chronic Infectious Disease
Glycomics by High-throughput Integrated Technologies (GlycoHIT) Oncology
High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation (TECHGENE)
High Throughput Proteomics Systems for Accelerated Profiling of Putative Plasma Biomarkers Cancers
Identification of new types of biomarkers and tracers for the in vivo molecular imaging of the pancreatic Beta-cell mass (KeyMarker) Type 2 Diabetes
Imaging Consortium for Drug Development Pain
Imaging of Neuroinflammation in Neurodegenerative Diseases (INMiND) Neurodegenerative Diseases
IMIDIA Diabetes
Inflammatory Bowel Disease Biomarkers Consortium (IBD BIOM) Irritable Bowel Disease
Innovative Medicines Initiative (IMI)
Innovative MODels Initiative (IMODI) Oncology
International AMD Gene Consortium Macular Degeneration
International Cancer Genome Consortium (ICGC) Oncology
International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) Irritable Bowel Disease
International Mouse Phenotyping Consortium (IMPC)
International Multiple Sclerosis Genetics (IMSG) Consortium Multiple Sclerosis
International Parkinson's Disease Genomics Consortium (IPDCG) Parkinson's Disease
International Rare Disease Research Consortium (IRDiRC) Rare Disease
International Serious Adverse Event Consortium (iSAEC)
International Thyroid Oncology Group (ITOG) Thyroid Cancer
Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2 (I-SPY 2) Oncology
LEISHDNAVAX (visceral leishmaniasis) visceral leishmaniasis
Lung Cancer Master Protocol (Lung-MAP) Squamous Lung Cancer
Lung Genomics Research Consortium (LGRC) Chronic obstructive pulmonary disease
Mammary Carcinoma Molecular Imaging for Diagnosis and Therapeutics (MAMMOTH) Oncology
Markers for Sub-Clinical Cardiovascular Risk Assessment (EU-MASCARA) Cardiovascular
Maximising Therapeutic Utility for Rheumatoid Arthritis (MATURA) Consortium Arthritis
Medulloblastoma Advanced Genomics International Consortium (MAGIC) Oncology
MetaHIT Obesity
Methods for systematic next generation oncology biomarker development (OncoTrack) Oncology
Microarray Quality Control (MAQC) Consortium
MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy (EpimiRNA) Consortium Epilepsy
MM4TB (More Medicines for Tuberculosis) Tuberculosis
Molecular Diagnosis and Risk Stratification of Sepsis (MARS) Consortium Sepsis
Monitoring Innate Immunity in Arthritis and Mucosal Inflammation (MIAMI) Arthritis
Mouse Sequencing Consortium (MSC)
MUGEN Immunological Diseases
Multiple Myeloma Research Foundation CoMMPass Study Multiple Myeloma
NanoNextNL
National Lung Matrix Trial (NLM) Oncology
Neoadjuvant Drug Treatment for Breast Cancer Response Prediction and Response Monitoring (Breast CARE) Oncology
Neurodegeneration Consortium (NDC) Alzheimer's Disease
NeurOmics Ataxia, Congenital muscular dystrophy, Congenital myasthenic syndrome...
New York Structural Genomics Research Consortium (NYSGRC)
Novel methods leading to new medications in depression and schizophrenia (NEWMEDS) Depression, Schizophrenia
ONCODEATH Cancers
Osteoarthritis Biomarkers Project (OABP) Arthritis
P1vital CNS Experimental Medicine Consortium Depression, Schizophrenia
Parkinson’s Progressive Marker Initiative (PPMI) Parkinson's Disease
PharmaCog Alzheimer's Disease
Placebo Data Analysis in Alzheimer’s Diseases/Mild Cognitive Impairment Alzheimer's Disease
Pneumopath Streptococcus pneumonaie
Polycystic Kidney Disease Outcomes Consortium Polycystic Kidney Disease
PRECISESADS Autoimmune Diseases
PREDICCt Type 2 Diabetes
Predictive Safety Testing Consortium
PROMEMORIA Consortium dysfunctional plasticity, cognitive impairment
Prostate Cancer Molecular Medicine (PCMM) Oncology
PROteomics SPECification in Time and Space
Psychiatric Genomics Consortium (PGC) Anorexia, Autism, Bipolar Disorder...
Quantitative Imaging in Cancer: Connecting Cellular Processes with Therapy (QuIC-ConCePT) Oncology
Rett Syndrome, MECP2 Duplication, and Rett-Related Disorders (RTT) Consortium Rett Syndrome
Sampling and Biomarker OPtimization and Harmonization In ALS and other motor neuron diseases (SOPHIA) Als
Standardisation and improvement of generic pre-analytical tools and procedures for in-vitro diagnostics (SPIDIA)
Sterol and Isoprenoid Research Consortium (STAIR) Cerebrotendinous Xanthomatosis, Hyperimmunoglobulinemia D With Periodic Fever Syndrome, Sitosterolemia...
Surrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Diabetes
SYBILLA
Synodos for NF2 Neurofibromatosis
Systems Biology towards novel chronic kidney disease diagnosis and treatment (SYSKID) Chronic Kidney Disease
Target-Melanoma: Molecular Dissection of Melanoma Progression: An Integrated Pan-European Approach Melanoma
TargetHerpes Herpes Virus
The Biomarkers Consortium
The development of new diagnostic tests, new tools and non-invasive methods for the prevention, early diagnosis and monitoring for haematopoietic stem cell transplantation (STEMDIAGNOSTICS) Oncology
The Epigenome Network of Excellence
The Forum for Collaborative HIV Research Hiv, Hepatitis C, Viral Hepatitis...
The ILSI Health and Environmental Science Institute (HESI)
The Inflammatory Bowel Disease CHARACTERization by a multi-modal integrated biomarker study (IBD-Character) Consortium Irritable Bowel Disease
The Molecular Evidence Development Consortium (MED-C) Cancers
The Neurofibromatosis Therapeutic Consortium (NFTC) Neurofibromatosis
The Personal Genome Sequencing Outcomes (PeopleSeq) Consortium
The Prostate Cancer Clinical Trials Consortium (PCCTC) Prostate Cancer
The Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) Neurofibromatosis
The Safer and Faster Evidence-based Translation (SAFE-T)
The Viral Hemorrhagic Fever Consortium Viral Hemorrhagic Fever, Lassa Fever, Ebola
Top Industry Pharma (TI Pharma)
Towards Early diagnosis and biomarker validation in Arthritis Management (EuroTEAM) Arthritis
TRanslational Initiative on Unique and novel strategies for Management of Patients with Heart failure (TRIUMPH) Heart Failure
Translational Research in Europe — Applied Technologies for Osteoarthritis (TREAT-OA) Arthritis
Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Diabetes
UK Dementias Research Platform Dementia
Unbiased BIOmarkers in PREDiction of respiratory disease outcomes Asthma
Wellcome Trust Case Control Consortium (WTCCC)
Worldwide Innovative Networking Consortium Oncology

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.